% | $
Quotes you view appear here for quick access.

SIGA Technologies Inc. Message Board

  • sigakingone sigakingone Jan 16, 2014 11:46 PM Flag



    Delaware Supreme Court Reverses Equitable Payment Stream to PharmAthene and Remands Litigation to Trial Court for New Determination of Damages

    NEW YORK, May 26, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA) reported today that the Delaware Supreme Court reversed the award of an "equitable payment stream" by the Court of Chancery in its May 31, 2012 Final Order and Judgment in PharmAthene, Inc. v. SIGA Technologies, Inc. and also remanded the case to the Court of Chancery for further proceedings to determine appropriate damages.

    William J. Haynes II, SIGA's General Counsel, commented, "We are pleased with the Delaware Supreme Court ruling issued on Friday. The Supreme Court's decision states that PharmAthene may only obtain damages for its lost expectancy if it can prove them 'with reasonable certainty.' We intend to establish to the Chancery Court, consistent with that Court's earlier conclusions, that PharmAthene's evidence of expectancy damages is speculative and too uncertain, contingent, and conjectural to permit an award."

    Dr. Eric A. Rose, SIGA's Chief Executive Officer, commented, "While legal proceedings may continue, we will now focus with even greater intensity on growing and enhancing SIGA's business, executing our existing contract with BARDA, seeking approval and licensing of Arestvyr™ from the U.S. Food and Drug Administration, and making greater use of our proven antiviral drug discovery and development capabilities."

    Long and Strong

    Sentiment: Strong Buy

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This has been discussed over and over, why throw out an old article-would be interesting to know what happened this week

      • 1 Reply to hosaquavas
      • owenscpa Jan 17, 2014 10:53 AM Flag

        That I think is king's point..... there isn't anything relevant to the stock price except what happens in court and what will happen in Parson's next ruling on damages and whether he uses contract law precedence or "creates" as PIP wants "new law".

        If he reverses his prior damages theory, it's IMO over, we win. If he doesn't, this still isn't over as generally a new position can continue to be tested against prior legal decisions.

        Since this is Parsons, and he hates SIGA; I give it better than 50/50 that the drama will continue for a number of years.

        Sentiment: Hold

0.87-0.0300(-3.33%)Jun 24 3:55 PMEDT